Affiliation:
1. Nanjing University of Chinese Medicine
2. Nanjing Hospital Affiliated to Nanjing Medical University (Nanjing First Hospital), China
3. Nanjing Hospital affiliated to Nanjing University of Chinese Medicine (Nanjing Second Hospital)
Abstract
Abstract
Background
Crohn's disease (CD) patients require varying levels of supportive care. In order to facilitate caregivers and nurses in precisely evaluating the caregiving requirements of these patients, we developed the CD-specific Care Needs Scale (CD-CNS).
Methods
Qualitative interviews were conducted based on the supportive care needs framework and Maslow's hierarchy of needs, and scale items were constructed through a literature search and qualitative interviews. The initial version of the scale with 45 items was obtained after the items were verified and modified by expert consultation. A total of 250 CD patients admitted to the gastroenterology department of a hospital in China were selected for verification of the initial version of the scale. A self-designed general questionnaire was used to obtain patients' medical history and sociodemographic data, and the Chinese version of the IBDQ was used as the criterion. Exploratory factor analysis (EFA) was performed on the CD-CNS to evaluate the dimensions, factor structure, reliability, criterion validity, and construct validity.
Results
EFA identified 5 dimensions and retained 27 items with strong internal consistency reliability (α = 0.94). The Cronbach's α coefficients for each dimension ranged from 0.824–0.921. Criterion validity was assessed using Spearman's coefficient, which demonstrated a significant correlation with the IBDQ (P < 0.050). The test-retest reliability for each dimension after two weeks ranged from 0.824–0.895.
Conclusions
We developed and validated a new scale that can be used to assess the care needs of CD patients. This new tool can guide the specific supportive care of CD patients.
Trial registration:
This study was reviewed and approved by the Ethics Committee of the Second Hospital of Nanjing (2021-LS-ky-022). It was duly registered and approved online through the Trial Center of the Second Hospital of Nanjing in 2021. Confidentiality was ensured by anonymizing all data. The entire study process was conducted under the supervision of the Ethics Committee of Nanjing Second Hospital. Informed consent was obtained from the patients, and each patient volunteered and agreed to participate.
Publisher
Research Square Platform LLC
Reference33 articles.
1. ,NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn's disease. Nature communications, Veauthier B, Hornecker JR. (2018). Crohn's Disease: Diagnosis and Management. American family physician, 98(11), 661–669.
2. Asia-Pacific consensus statements on Crohn's disease. Part 2: Management;Ooi CJ;J Gastroenterol Hepatol,2016
3. The diagnosis and treatment of Crohn's disease and ulcerative colitis;Baumgart DC;Dtsch Arztebl Int,2009
4. Crohn's disease: a population-based study of surgery in the age of biological therapy;Stöss C;Int J Colorectal Dis,2021
5. ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment;Adamina M;J Crohns Colitis,2020